A quick peek into the report
Table of Contents
1 REPORT OVERVIEW
1.1 REPORT SCOPE & REPORT COVERAGE
1.1.1 MARKET SEGMENTATION
1.2 RESEARCH METHODOLOGY
1.2.1 DATA TRIANGULATION
1.2.2 TOP-DOWN APPROACH
1.2.3 BOTTOM-UP APPROACH
1.2.4 ASSUMPTIONS & LIMITATIONS
1.3 KEY DATA POINT SOURCES
1.3.1 KEY DATA POINTS FROM SECONDARY SOURCES
1.3.2 KEY DATA POINTS FROM PRIMARY SOURCES
1.4 REPORT DESCRIPTION
2 EXECUTIVE SUMMARY
2.1 GLOBAL MARKET SCENARIO
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 TIMELINE
3.3 ECOSYSTEM PLAYERS OF GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET
3.4 CARRIER FREQUENCIES BASED ON ETHNIC ORIGIN
3.5 INDICATIONS FOR PRENATAL AND NEWBORN TESTING
3.6 BENEFITS AND RISKS OF PRENATAL TESTING & NEWBORN SCREENING
3.7 MARKET DYNAMICS
3.7.1 MARKET DRIVERS
3.7.2 MARKET CHALLENGES
3.7.3 MARKET OPPORTUNITIES
4 COMPETITIVE INSIGHTS
4.1 KEY MARKET DEVELOPMENT & STRATEGIES
4.2 PORTER'S FIVE FORCES ANALYSIS
4.2.1 BARGAINING POWER OF BUYERS
4.2.2 BARGAINING POWER OF SUPPLIER
4.2.3 THREAT FROM SUBSTITUTE
4.2.4 THREAT OF NEW ENTRANT
4.2.5 INTENSITY OF COMPETITIVE RIVALRY
5 INDUSTRY ANALYSIS
5.1 ASSOCIATIONS, CONSORTIUM AND REGULATORY BODIES
5.2 PATENT ANALYSIS
5.3 VALUE CHAIN ANALYSIS
6 GLOBAL PRENATAL TESTING MARKET
6.1 INTRODUCTION
6.2 MARKET INSIGHTS
6.3 TYPES OF GENETIC DISEASES IN FETUSES: AN OVERVIEW
6.4 MARKET STATISTICS
6.5 PRENATAL TESTING MARKET BY TECHNIQUES
6.5.1 SCREENING METHODS
6.5.2 DIAGNOSIC TECHNIQUES
6.6 PRENATAL TESTING TIMELINE DURING PREGNANCY
6.7 NIPT: KEY INSIGHTS
6.8 PRENATAL TESTING TECHNIQUES: SEGMENTATION ON THE BASIS OF TECHNOLOGY
6.9 RECENT DEVELOPMENTS & KEY PLAYERS
7 GLOBAL NEWBORN SCREENING TESTING MARKET
7.1 MARKET INSIGHTS & STATISTICS
7.2 MARKET STATISTICS
7.3 TARGETED DISORDERS IN NEWBORN SCREENING
7.4 STANDARD PROCESSS IN NEWBORN SCREENING
7.5 RECENT DEVELOPMENTS & KEY MARKET PLAYERS
8 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET BY GEOGRAPHY
8.1 GEOGRAPHICAL SCENARIO
8.2 MARKET STATISTICS
8.3 NORTH AMERICA
8.3.1 NORTH AMERICA: MARKET STATISTICS
8.3.2 THE U.S.
8.3.3 RECENT DEVELOPMENTS & KEY MARKET PLAYER
8.4 EUROPE
8.4.1 EUROPE: MARKET STATISTICS
8.4.2 EUROPE: MARKET STATISTICS OF KEY COUNTRIES
8.4.3 RECENT DEVELOPMENTS & KEY MARKET PLAYERS
8.5 ASIA-PACIFIC (APAC)
8.5.1 APAC: INSIGHTS & MARKET STATISTICS
8.5.2 APAC: MARKET STATISTICS
8.5.3 CHINA: MARKET STATISTICS
8.5.4 INDIA: MARKET STATISTICS
8.5.5 RECENT DEVELOPMENTS & KEY PLAYERS
8.6 REST OF THE WORLD (ROW)
8.6.1 ROW: MARKET STATISTICS
8.6.2 MIDDLE EAST: KEY INSIGHTS
9 GLOBAL PRENATAL TESTING & NEWBORN SCREENING: KEY PLAYERS
9.1 ILLUMINA, INC.
9.1.1 SUMMARY & FINANCIALS
9.2.2 KEY DEVELOPMENTS
9.2.3 SWOT ANALYSIS
9.2 LABORATORY CORPORATION OF AMERICA HOLDINGS
9.2.1 SUMMARY & FINANCIALS
9.2.2 KEY DEVELOPMENTS
9.2.3 SWOT ANALYSIS
9.3 NATUS MEDICAL INCORPORATED
9.3.1 SUMMARY & FINANCIALS
9.3.2 KEY DEVELOPMENTS
9.3.3 SWOT ANALYSIS
9.4 PERKINELMER, INC.
9.4.1 SUMMARY & FINANCIALS
9.4.2 KEY DEVELOPMENTS
9.4.3 SWOT ANALYSIS
9.5 QUEST DIAGNOSTICS INC.
9.5.1 SUMMARY & FINANCIALS
9.5.2 KEY DEVELOPMENTS
9.5.3 SWOT ANALYSIS
9.6 OTHER EMERGING PLAYERS
LIST OF FIGURES
1 RESEARCH METHODOLOGY
2 YEAR CONSIDERATION FOR REPORT
3 GLOBAL PRENATAL TESTING & NEWBORN SCREENING GENETIC TESTING MARKET ($BILLION)
4 GLOBAL PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
5 GLOBAL PRENATAL & NEWBORN GENETIC TESTING MARKET SHARE, BY GENETIC TEST, 2015-2022 ($BILLION)
6 GLOBAL PRENATAL & NEWBORN GENETIC TESTING MARKET SHARE, BY TECHNIQUES, 2015-2022 ($BILLION)
7 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2015 – 2022 ($BILLION)
8 TIMELINE SHOWING INCREASING NUMBER OF DISORDERS SCREENED IN A TEST
9 INDICATIONS FOR PRENATAL AND NEWBORN TESTING
10 MARKET DYNAMICS
11 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET COMPETITIVE INSIGHTS
12 PORTER’S FIVE FORCES ANALYSIS
13 VALUE CHAIN ANALYSIS
14 EXAMPLE OF SOME COMMON ACTS
15 LIVE BIRTH RATE - RISK OF GENETIC ABNORMALITY/DISORDERS BY MATERNAL AGE
16 ABILITY OF DIAGNOSTIC & SCREENING TECHNICHES TO DETECT GENETIC DISORDER
17 GLOBAL PRENATAL TESTING MARKET, 2015-2022 ($BILLION)
18 GLOBAL PRENATAL TESTING MARKET, BY TECHNIQUES -2015
19 GLOBAL PRENATAL TESTING MARKET, BY NATURE OF TEST -2015
20 GLOBAL PRENATAL TESTING MARKET, BY TECHNIQUES, 2015-2022 ($BILLION)
21 GLOBAL PRENATAL TESTING MARKET, BY NATURE OF TEST, 2015-2022 ($BILLION)
22 GLOBAL PRENATAL TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($BILLION)
23 GLOBAL PRENATAL TESTING MARKET, BY GEOGRAPHY -2015
24 GLOBAL PRENATAL TESTING MARKET, BY SCREENING METHODS, 2015-2022 ($BILLION)
25 BENEFITS OF SCREENING METHODS
26 GLOBAL PRENATAL TESTING MARKET, BY DIAGNOSTIC TECHNIQUES, 2015-2022 ($BILLION)
27 BENEFITS OF DIAGNOSTIC TECHNIQUES
28 PRENATAL TESTING TIMELINE DURING PREGNANCY (TILL SECOND TRIMESTER)
29 DIAGNOSTIC TECHNIQUES BY INVASIVE TECHNOLOGY
30 GLOBAL PRENATAL TESTING MARKET, BY TECHNOLOGY-2015
31 GLOBAL NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
32 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2015-2022 ($BILLION)
33 GLOBAL NEWBORN SCREENING MARKET, BY GEOGRAPHY -2015
34 TARGETED DISORDERS IN NEWBORN SCREENING
35 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET-2015
36 GLOBAL PRENATAL & NEWBORN SCREENING MARKET, BY GEOGRAPHY, 2015-2022 ($BILLION)
37 GLOBAL PRENATAL TESTING & NEWBORN SCREENING MARKET, BY GEOGRAPHY (2015)
38 NORTH AMERICA PRENATAL TESTING & NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
39 NORTH AMERICA PRENATAL TESTING & NEWBORN SCREENING MARKET, BY SUB-REGION, 2015-2022 ($BILLION)
40 NORTH AMERICA PRENATAL TESTING MARKET 2015-2022 ($BILLION)
41 THE U.S. PRENATAL TESTING & NEWBORN SCREENING, 2015-2022 ($BILLION)
42 THE U.S. PRENATAL TESTING & NEWBORN SCREENING, 2015-2022 ($BILLION)
43 EUROPEAN PRENATAL TESTING & NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
44 EUROPEAN PRENATAL TESTING & NEWBORN SCREENING MARKET, BY SUB-REGION, 2015-2022 ($BILLION)
45 EUROPEAN PRENATAL TESTING & NEWBORN SCREENING MARKET, BY COUNTRIES, 2015-2022 ($BILLION)
46 APAC: COUNTRY-WISE CAGR OF PRENATAL TESTING AND NEWBORN SCREENING MARKET
47 APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
48 APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
49 CHINA’S MARKET SHARE IN APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET-2015
50 CHINA’S PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
51 INDIA’S MARKET SHARE IN APAC PRENATAL TESTING AND NEWBORN SCREENING MARKET-2015
52 INDIA’S PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
53 CHALLENGES FOR PRENATAL TESTING AND NEWBORN SCREENING IN INDIA
54 REGION-WISE CAGR OF PRENATAL TESTING AND NEWBORN SCREENING MARKET
55 ROW PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
56 ROW PRENATAL TESTING AND NEWBORN SCREENING MARKET, BY SUB-REGION, 2015-2022 ($BILLION)
57 ROW PRENATAL TESTING AND NEWBORN SCREENING MARKET, 2015-2022 ($BILLION)
58 ILLUMINA, INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
59 ILLUMINA, INC. - FINANCIALS BY BUSINESS SEGMENTS, 2013-2015, ($MILLION)
60 ILLUMINA, INC. - FINANCIALS BY GEOGRAPHY, 2013-2014 ($MILLION)
61 ILLUMINA, INC. - SWOT ANALYSIS
62 LABCORP- OVERALL FINANCIALS, 2013-2015, ($MILLION)
63 LABCORP- FINANCIALS BY BUSINESS SEGMENTS, 2013-2014, ($MILLION)
64 LABCORP- SWOT ANALYSIS
65 NATUS MEDICAL INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
66 NATUS MEDICAL INC. - FINANCIALS BY PRODUCT TYPE, 2013-2015, ($MILLION)
67 NATUS MEDICAL INC. - FINANCIALS BY GEOGRAPHY, 2013-2015, ($MILLION)
68 NATUS MEDICAL INC. - FINANCIALS BY END MARKET, 2013-2015, ($MILLION
69 NATUS MEDICAL INC. - FINANCIALS BY NEWBORN CARE (2015)
70 NATUS MEDICAL INCORPORATED- RECENT DEVELOPMENTS
71 PERKINELMER, INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
72 PERKINELMER, INC. - FINANCIALS BY BUSINESS SEGMENTS, 2013-2015, ($MILLION)
73 PERKINELMER, INC. - FINANCIALS BY GEOGRAPHY, 2013-2014, ($MILLION)
74 QUEST DIAGNOSTICS INC. - OVERALL FINANCIALS, 2013-2015, ($MILLION)
75 QUEST DIAGNOSTICS INC. - FINANCIALS BY BUSINESS SEGMENTS, 2013-2014, ($MILLION)
76 QUEST DIAGNOSTICS INC. - SWOT ANALYSIS
LIST OF TABLES
1 CARRIER FREQUENCIES BASED ON ETHNIC ORIGIN
2 ASSOCIATIONS, CONSORTIUM AND REGULATORY BODIES
3 PATENT ANALYSIS
4 TYPES OF GENETIC DISEASES IN FETUSES: AN OVERVIEW
5 SCREENING METHODS: SOME EXAMPLES
6 DIAGNOSIC TECHNIQUES: SOME EXAMPLES
7 TARGETED DISORDERS IN NEWBORN SCREENING
8 INCIDENCE RATE FOR SOME GENETIC DISEASES IN INDIA
9 ILLUMINA, INC. - RECENT DEVELOPMENTS
10 LABCORP- RECENT DEVELOPMENTS
11 NATUS MEDICAL INCORPORATED- RECENT DEVELOPMENTS
12 PERKINELMER, INC. - RECENT DEVELOPMENTS
13 PERKINELMER, INC. - SWOT ANALYSIS
14 QUEST DIAGNOSTICS INC. - RECENT DEVELOPMENTS
15 OTHER EMERGING PLAYERS
16 LIST OF ACCRONYMS
Key Questions Answered in this Report
The answers to the following key questions can be found in the report:
• What are the major market drivers, challenges and opportunities of the prenatal testing and newborn screening market and their use cases?
•What are the key trends and developments in the prenatal testing and newborn screening market for genetic disease management?
•What are the key developmental strategies in different applications across all regions?
•What are different types of prenatal tests and newborn screening methods and the latest technologies entering the market?
•How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launches among others?
•Which geographical region will lead the global prenatal testing and newborn screening market by the end of the forecast period?
•Who are the key players in the prenatal testing and newborn screening market?
•What are the key government regulations for different prenatal testing and newborn screening solutions?
•What are the key market trends and key developments in different geographical regions?
•What are the genetic disorders detectable by different prenatal screening and diagnostic tests?
•What are the appropriate technologies for the detection of aneuploidies, micro-deletions, duplications, copy number variations and translocations?
•What different noninvasive and invasive prenatal screening tests are performed during a pregnancy?
•What is the global and regional market for newborn screening tests, through 2022?
•What is the global market for newborn screening tests by technology, through 2022?
•What are the detection rate, true positive rate and true negative rate for common NIPTs?
•What is the global and regional market for NIPTs using cell free fetal DNA, through 2022?
•How many genetic conditions are detected during newborn genetic screening in the U.S.?
•What is the status of newborn genetic screening in developed, developing and other countries?
•What are the currently used advanced technologies in prenatal and newborn testing?
Report Description
With the emergence of advanced technologies such as next generation sequencing, high throughput screening (HTS), and cell free fetal DNA, there has been a rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests. Presently, the main focus of the government initiatives is mainly towards developing non-invasive solutions, launching large number of newborn screening programs, controlling the increasing level of genetic disorders, and integrating advanced technologies to fulfill the unmet needs of the patients.
Governmental regulations and standards are playing a major role in sustaining the growth and development of the market. The main aim of these regulations is to make prenatal tests and solutions more adaptable and focused towards effective diagnosis of various genetic disorders & chromosomal abnormalities. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive accurate and proper diagnosis & screening of the disease.
This study includes an overview and analysis of the prenatal and newborn genetic testing market, by type of tests, techniques, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The prenatal and newborn genetic testing market report presents a detailed analysis of market dynamics and provides an extensive insight into various forms of developments, trends and key participants. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC), and Rest of the World (ROW).
While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, as well as their involvement in the prenatal and newborn genetic testing market. The research incorporates Porter’s Five Force Model for an in-depth analysis of the prenatal and newborn genetic testing market and an assessment of the factors governing it. The analysis builds on a well-compiled value chain giving a detailed understanding of the ecosystem players and their market penetration.
The report includes the profiles of major players in the prenatal testing and newborn screening market that allows the readers to gain an insight into the various industry trends.
Market Overview
Prenatal Testing and Newborn Screening is one of the most modernized trends in the healthcare industry which has shown a tremendous level of progress in the last few years. The growth of prenatal and newborn genetic testing market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, and advancement of healthcare technologies. The global prenatal and newborn genetic testing market has a high growth potential in future and will grow over $10.63 billion by the end of forecast period. With the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA, there has been a gradual rise in the overall demand of the newly developed prenatal diagnosis and newborn screening tests.
Factors such as legal approval of the prenatal testing and newborn screening in most of the states of the U.S. government investment & regulations, and healthcare policies of other developed and emerging countries are contributing to the overall market growth.
The report has been further classified into prenatal testing and newborn screening. Prenatal testing further segmented on the basis of techniques (diagnostic & screening) and nature of the test (invasive & non-invasive). Prenatal testing is dominating the market and growing at a CAGR of 27.98% from 2016 to 2022.
Diagnosis technologies are holding the maximum market share and are expected to grow at 26.54% CAGR from 2016 to 2022. The techniques can either be invasive and non-invasive. By studying the current trends, it can be said that non-invasive prenatal testing are gaining more traction from the patients. Lifestyle preferences such as smoking, drinking, obesity, increasing maternity age, and genetic disorders are some of the factors responsible for the growth of the market.
North America is the largest contributor in the overall revenue generation in prenatal and newborn care, followed by the European region, and is expected to grow at a CAGR of 23.36% from 2016 to 2022. While the U.S., the U.K., Japan, and India show a dynamic growth in the overall market due to an increasing prevalence of genetic disorders in these countries. Moreover, APAC region is focusing more on technological developments and introduction of new advanced tools in the field of prenatal and newborn care in order to develop specific tests and solutions.
Global Prenatal Testing and Newborn Screening Market
Forecast 2016-2022